Siegfried To Create Functional Organization
Rudolf Hanko, CEO of Siegfried, said: “Siegfried is one of the rare suppliers of the pharmaceutical industry that is capable of providing both the chemical synthesis of active

Rudolf Hanko, CEO of Siegfried, said: “Siegfried is one of the rare suppliers of the pharmaceutical industry that is capable of providing both the chemical synthesis of active

As per the terms of the co-marketing alliance the companies will jointly promote the use of a new synthetic-ligand affinity adsorbent, marketed under the trade-name AlbuPure, as a

The newly issued patent (US 7,655,252) is licensed from the University of Michigan to NanoBio on an exclusive, worldwide basis. With the new patent, NanoBio now holds six

XM02 is a granulocyte colony-stimulating factor (G-CSF) for reducing the duration of severe neutropenia and the incidence of febrile neutropenia, in patients treated with established myelosuppressive chemotherapy for

Reportedly, SynCo has commenced with preparations for the manufacture of conformance lots in advance of its client’s BLA filings, expected in late 2010, in anticipation of commercial manufacturing

The company said that once the review is completed, they intend to move forward a fully-compliant 510(k) submission. The submission will be based on the regulatory strategy and

The company claims that Tjet uses a needle-free delivery system that releases the same amount of Tev-Tropin as a traditional syringe in two seconds. Tjet works by releasing

Reportedly, ’835 case is related to an earlier patent, US Patent No 7,544,506, issued to Micronics. The devices of these patents make it possible to perform PCR or

As part of the agreement, KMOT is expected to purchase prototype devices and rely on GT for establishing the technical approach and regulatory strategy for potential entry of

The company said that they have the final color and taste of the tablet, and managed to meet their end goal of having a tablet that dissolves in